Tempus AI and Pathos AI Sign Neurology Data Deal Worth Up to $55 Million

Your call?🐂 Bullish🐻 Bearish

$55M

data deal value

Tempus will seek to license Pathos 500,000 de-identified records over five years; Bristol Myers Squibb will get Foundry access and three-year exclusive rights to support its neuroscience development programs.